Partial Courses of Fidaxomicin Followed by Oral Vancomycin and the Effect on Recurrence of Clostridioides difficile Infections
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280251332946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Irene-Constantina Papamanolis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Carilion Roanoke Memorial Hospital, Carilion Clinic, Roanoke, VA, USA. Hauptthemen laut MEDLINE: Vancomycin, Clostridium Infections, Anti-Bacterial Agents, Clostridioides difficile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Clostridioides difficile infection (CDI) causes a significant national health care burden. Literature has demonstrated lower rates of CDI recurrence with fidaxomicin compared with oral vancomycin. However, patients are sometimes switched to oral vancomycin before completing a fidaxomicin course.
Objective
The objective of this study is to evaluate rates of CDI recurrence in full courses of fidaxomicin versus partial courses of fidaxomicin followed by a switch to oral vancomycin.
Methods
In this single-center, retrospective, cohort study of adults with CDI, patients were screened for inclusion if they received either a full 10-day course of fidaxomicin or partial course of fidaxomicin followed by a switch to oral vancomycin. The primary outcome was the rate of CDI recurrence within 30 days after completion of initial therapy determined by a positive CDI test and initiation of treatment.
Results
Ninety-nine patients received a full course of fidaxomicin, and 95 patients received a partial course of fidaxomicin followed by oral vancomycin. Mean age was lower in the full course group compared with the partial course (65.3 years vs 71.5 years, P < 0.002). Clostridioides difficile infection recurrence occurred in 5.1% of the full course group and 7.4% of the partial therapy group ( P = 0.503) at 30 days and 13.1% versus 14.7% ( P = 0.747) at 90 days. Clostridioides difficile infection–related readmissions at 30 days were similar in the full course and partial course groups (7.1% vs 4.2%, P = 0.389). Conclusion and Relevance: Partial courses of fidaxomicin followed by oral vancomycin had similar 30-day CDI recurrence compared with full course fidaxomicin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Carilion Roanoke Memorial Hospital, Carilion Clinic, Roanoke, VA, USA.
- University Hospital, Newark, NJ, USA.
- Henry Ford Hospital, Detroit, MI, USA.
- Children's Healthcare of Atlanta, Atlanta, GA, USA.
ORCID-Profile: Nathan Everson, Lauren McDaniel
Zitieren
APA
Papamanolis, I. C., Stornelli, N., Everson, N., Ahmad, Z., Kamrada, M., Lockhart, E. R., & McDaniel, L. (2025). Partial Courses of Fidaxomicin Followed by Oral Vancomycin and the Effect on Recurrence of Clostridioides difficile Infections. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251332946
Vancouver
Papamanolis IC, Stornelli N, Everson N, Ahmad Z, Kamrada M, Lockhart ER, et al. Partial Courses of Fidaxomicin Followed by Oral Vancomycin and the Effect on Recurrence of Clostridioides difficile Infections. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251332946
BibTeX
@article{Papamanolis2025,
author = {Papamanolis, Irene-Constantina and Stornelli, Nicholas and Everson, Nathan and Ahmad, Zayd and Kamrada, Meghan and Lockhart, Ellen Rachel and McDaniel, Lauren},
title = {Partial Courses of Fidaxomicin Followed by Oral Vancomycin and the Effect on Recurrence of Clostridioides difficile Infections},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280251332946}
}
EUVIMED